Avidity's stock soars on news of expanded collaboration with Bristol Myers that includes potential to receive up to $2.2 billion in milestone payments

Avidity's stock soared 30.5% early Tuesday on news of an expanded collaboration with Bristol Myers.

Related Keywords

Bristol Myers ,Avidity Biosciences Inc ,Bristol Myers Squibb Co ,Avidity Biosciences ,Bristol Myers Squibb ,Antibody Oligonucleotide Conjugates ,Article Normal ,Biotechnology ,Pharmaceuticals ,Health Care ,Broadcasting ,Radio Broadcasting ,Media Entertainment ,Ownership Changes ,Acquisitions Mergers Shareholdings ,Corporate Actions ,Corporate Industrial News ,Political General News ,Health ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Rna ,Spx ,S Amp Ampp 500 Index ,Acquisitions ,Mergers ,Shareholdings ,Corporate ,Industrial News ,Political ,General News ,Media ,Entertainment ,